KALV 10.69 (+1.14%)
US4834971032BiotechnologyBiotechnology

KalVista Pharmaceuticals (KALV) Stock Highlights

10.69 | +1.14%
2024-09-19 04:25:59
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The companys product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States.

Statistics

Range Today
10.55 10.99
Volume Today 249.4K
Range 1 Year
7.21 16.88
Volume 1 Year 113.39M
Range 3 Year
4.12 19.19
Volume 3 Year 247.98M
Range 10 Year
4.12 129.108
Volume 10 Year 454.71M

Highlights

Market Capitalization 481.42M (small)
Floating Shares 21.86M
Current Price 10.69
Price To Earnings -2.78
Price To Book 2.78
Earnings Per Share -3.81
Payout Ratio 0%

Performance

Latest +1.14%
1 Month -10.92%
3 Months -9.18%
6 Months -10.32%
1 Year +8.75%
3 Years -42.74%
5 Years -27.03%
10 Years -88.25%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.